⚠️ Important Notice

This guide is for educational purposes only. Hormone therapy requires medical supervision and individualized protocols. We do not provide dosing recommendations—that is the domain of qualified physicians. Our goal is to help you understand endocrine health so you can have informed conversations with healthcare providers and make intelligent decisions about optimization. Self-treatment with hormones carries significant risks.

1. The Endocrine Orchestra: Why Hormones Matter

Hormones are the chemical messengers that orchestrate virtually every process in your body. They regulate metabolism, growth, reproduction, mood, cognition, sleep, immune function, and how you respond to stress. When this orchestra plays in harmony, you experience what we call vitality—energy, mental clarity, emotional stability, physical capability, and resilience.

When hormones fall out of balance—whether through aging, lifestyle factors, environmental exposure, or disease—the effects cascade through every system. Fatigue, brain fog, weight gain, mood disturbances, loss of motivation, declining physical performance, and accelerated aging are all potential consequences of hormonal dysfunction.

Testosterone
Drive, muscle, metabolism, mood
🌸
Estrogen
Bone, brain, cardiovascular, skin
🌙
Progesterone
Sleep, calm, neuroprotection
🔥
Thyroid
Metabolism, energy, temperature
📈
Growth Hormone
Recovery, body comp, anti-aging
🛡️
Cortisol
Stress response, inflammation

The Modern Hormonal Crisis

We are witnessing a population-level decline in hormonal health that transcends normal aging. Testosterone levels in men have dropped approximately 1% per year since the 1980s—a man today has significantly lower testosterone than his father did at the same age.[1] Women are experiencing earlier perimenopause and more severe symptoms. Thyroid dysfunction affects an estimated 20 million Americans, with up to 60% undiagnosed.[2]

The causes are multifactorial: environmental endocrine disruptors (plastics, pesticides, industrial chemicals), chronic stress, sleep deprivation, obesity, sedentary lifestyles, and dietary factors. Understanding these influences is the first step toward reclaiming hormonal health.

The Optimization Mindset

Hormone optimization is not about achieving supraphysiological levels or anti-aging magic. It's about restoring function to levels that support health, vitality, and quality of life. For some, this means lifestyle interventions alone. For others, it requires medical therapy. The goal is the same: feeling and functioning at your best for as long as possible.

This guide covers the major hormonal systems, their interactions, how to test them properly, and what interventions—natural and pharmaceutical—have evidence behind them. We'll also address practical considerations: finding qualified providers, understanding the DIY landscape, and building a personalized optimization strategy.

2. The HPA Axis: Master Control System

Before diving into specific hormones, it's essential to understand the master control system that regulates them: the Hypothalamic-Pituitary-Adrenal (HPA) axis and its related systems (HPT for thyroid, HPG for gonads). These feedback loops determine how much of each hormone your body produces.

The Hypothalamic-Pituitary-Gonadal (HPG) Axis

Hypothalamus
Releases GnRH (Gonadotropin-Releasing Hormone)
Pituitary Gland
Releases LH & FSH
Gonads
Testes (T) or Ovaries (E2, P4)
Target Tissues
Muscles, Brain, Bone, etc.
↑ Negative Feedback ↑

High hormone levels signal the hypothalamus and pituitary to reduce stimulation. This is why exogenous hormones suppress natural production.

Why Axis Function Matters

Understanding axis function is critical for several reasons:

The Stress-Hormone Connection

The HPA axis (stress response) directly interfaces with the HPG axis (sex hormones) and HPT axis (thyroid). Chronic stress and elevated cortisol:

💡 The Cortisol-Testosterone Seesaw

Cortisol and testosterone have an inverse relationship. When cortisol is chronically elevated, testosterone suffers. This is one reason why stressed, overworked individuals often have low T despite being otherwise healthy. Stress management isn't just about feeling better—it's about protecting your entire endocrine system.

Key Regulatory Hormones

LH (Luteinizing Hormone)
Pituitary Hormone

In men, LH stimulates Leydig cells in the testes to produce testosterone. In women, LH triggers ovulation and supports corpus luteum function.

Male Range
1.7-8.6 mIU/mL
Female (Follicular)
2.4-12.6 mIU/mL

Clinical significance: Low LH with low sex hormones suggests secondary hypogonadism (pituitary/hypothalamic problem). High LH with low sex hormones suggests primary hypogonadism (gonadal failure).

FSH (Follicle-Stimulating Hormone)
Pituitary Hormone

In men, FSH stimulates Sertoli cells, supporting spermatogenesis. In women, FSH stimulates follicle development and estrogen production.

Male Range
1.5-12.4 mIU/mL
Female (Follicular)
3.5-12.5 mIU/mL

Clinical significance: Elevated FSH in women often indicates diminished ovarian reserve (perimenopause). In men, high FSH suggests testicular dysfunction affecting sperm production.

3. Testosterone & Male Hormone Optimization

We've covered testosterone extensively in our dedicated Testosterone Guide. Here, we'll focus on practical protocol details, delivery methods, and the nuances of TRT management that physicians consider when designing treatment.

When TRT Makes Sense

The decision to start testosterone replacement therapy involves both objective criteria (lab values) and subjective factors (symptoms). The Endocrine Society guidelines recommend treatment for men with:[4]

💡 The Symptom-Level Disconnect

Some men feel great at 400 ng/dL; others feel terrible at 500 ng/dL. Individual sensitivity to androgens varies based on androgen receptor density, SHBG levels, and other factors. Treatment decisions should consider both numbers and symptoms.

TRT Protocols & Delivery Methods

Injectable Testosterone
Gold Standard

Intramuscular (IM) or subcutaneous (SubQ) injections remain the most effective and cost-efficient method of testosterone delivery. Modern protocols favor frequent, smaller injections for more stable levels.

Common Esters

Ester Half-Life Typical Protocol Notes
Testosterone Cypionate ~8 days 50-80mg 2x/week or 100-200mg weekly Most common in US; oil-based
Testosterone Enanthate ~7 days 50-80mg 2x/week Interchangeable with cypionate
Testosterone Propionate ~2 days 20-30mg every other day More frequent injections; faster clearance
Testosterone Undecanoate ~21 days 750-1000mg every 10-14 weeks Long-acting; requires clinic injection

Injection Frequency: The Modern Approach

Traditional protocols used weekly or biweekly injections, causing significant peak-trough fluctuations. Many men experienced a "roller coaster" effect—feeling great for a few days after injection, then symptoms returning as levels dropped.

Modern optimization clinics increasingly favor:

  • Twice weekly injections — Most common compromise between stability and convenience
  • Every-other-day (EOD) — Even more stable; preferred by high-aromatizers
  • Daily microdosing — Maximum stability; mimics natural circadian rhythm most closely

More frequent injections generally mean: more stable mood and energy, lower estrogen conversion (lower peaks = less aromatization), and reduced need for ancillary medications.

Subcutaneous vs. Intramuscular

  • Subcutaneous (SubQ): Smaller needles (27-30G), inject into abdominal or thigh fat, virtually painless, slower absorption (more stable levels), may result in slightly lower peak levels
  • Intramuscular (IM): Larger needles (23-25G), inject into deltoid, glute, or quad muscle, faster absorption, traditional method

Both methods are effective. SubQ has become popular for frequent dosing due to convenience and comfort.

Topical Testosterone
Alternative

Gels, creams, and solutions applied daily to skin. Best for those who prefer no injections and can accept the limitations.

Options

  • Commercial gels (AndroGel, Testim, Fortesta): Standardized doses, insurance coverage possible, alcohol-based
  • Compounded creams: Custom concentrations, often better absorption, applied to scrotum or other thin-skin areas for enhanced absorption
  • Natesto (nasal gel): 3x daily application, doesn't suppress LH/FSH as much (maintains some fertility), but inconvenient

Considerations

Pros Cons
No injections Transfer risk to partners/children
Daily application mimics circadian rhythm Variable absorption (some are "poor absorbers")
Easy to adjust or discontinue May not achieve optimal levels
Higher DHT conversion (scrotal application) More expensive than injectable

Scrotal application: Compounded creams applied to the scrotum show 5-8x higher absorption and significantly increased DHT production. Some men report enhanced libido and well-being with this method, though it requires careful monitoring.[5]

Testosterone Pellets
Long-Acting

Subcutaneous implants placed every 3-6 months via minor office procedure.

Duration
3-6 months
Typical Dose
600-1200mg total
Extrusion Rate
~8-10%

Best for: Those who want convenience and stable levels without frequent administration. Downsides: Can't adjust once implanted, levels decline toward end of cycle, extrusion risk, requires office visits.

TRT Monitoring & Management

Proper monitoring on TRT prevents complications and ensures optimal outcomes. Here's what should be tracked and why:

Essential Monitoring Panel
Marker Timing Target/Concern
Total Testosterone 6-8 weeks, then every 6-12 months Mid-range to upper-normal (600-900 ng/dL)
Free Testosterone With total T 15-25 ng/dL (symptoms correlate better)
Estradiol (sensitive) With testosterone 20-40 pg/mL; avoid extremes
Hematocrit/Hemoglobin Baseline, 3-6 months, then annually Hematocrit <54%; donate blood if elevated
PSA Baseline, 3-6 months, then annually Watch for significant increases (>1.4 ng/mL/year)
Lipid Panel Baseline, then annually Monitor HDL (may decrease); LDL changes
Metabolic Panel Baseline, then annually Liver, kidney function

Managing Estradiol

Testosterone converts to estradiol via the aromatase enzyme. Proper estrogen levels are essential—both too high and too low cause problems.

🔺 Estrogen Too High

  • Water retention, bloating
  • Gynecomastia (breast tissue)
  • Emotional volatility
  • Erectile dysfunction
  • Reduced libido (paradoxically)

🔻 Estrogen Too Low

  • Joint pain and stiffness
  • Low libido
  • Depression, anxiety
  • Poor bone health
  • Cognitive issues

First-line management: Adjust injection frequency. More frequent, smaller doses reduce peak testosterone, which reduces aromatization.

Aromatase inhibitors (AI): Anastrozole (Arimidex) blocks estrogen production. Should be used sparingly and titrated carefully—many clinics over-prescribe AIs, crashing estrogen and causing more problems than they solve. Low-dose (0.25mg 1-2x/week) is typical when needed.[6]

⚠️ The AI Trap

Don't reflexively take an AI just because your estradiol is "high" on paper. If you feel good with no symptoms of high E2, you probably don't need one. Many men function best at E2 levels of 30-50 pg/mL—above what some protocols target. Always dose by symptoms, not just numbers.

Managing Hematocrit

Testosterone increases red blood cell production (erythropoiesis). Elevated hematocrit increases blood viscosity and theoretical cardiovascular risk.

Adjunctive Medications

hCG (Human Chorionic Gonadotropin)
LH Mimetic

hCG mimics LH, stimulating the testes to maintain function and intratesticular testosterone production. Often co-prescribed with TRT.

Typical Dose
250-500 IU 2-3x/week
Purpose
Testicular maintenance

Benefits

  • Maintains testicular size and function
  • Preserves some fertility potential
  • Maintains intratesticular testosterone (important for spermatogenesis)
  • May improve mood and well-being (some men report this)
  • Maintains pregnenolone and DHEA production

Considerations

  • Increases estrogen (aromatization occurs in testes)
  • Adds complexity and cost
  • Not a substitute for TRT—usually used alongside

Alternatives to TRT

For men who want to preserve fertility or aren't ready to commit to TRT, several alternatives can raise testosterone while maintaining HPG axis function:

Clomiphene Citrate (Clomid)
SERM

A selective estrogen receptor modulator that blocks estrogen feedback at the hypothalamus/pituitary, increasing LH/FSH and natural testosterone production.

Typical Dose
12.5-50mg daily or EOD
T Increase
~150-400 ng/dL

Moderate Evidence

Pros

  • Preserves fertility (increases sperm production)
  • Maintains testicular function
  • Oral medication (no injections)
  • Reversible

Cons

  • Less effective than TRT at raising T
  • Some men report not "feeling" the effects as much
  • Visual disturbances in some individuals
  • Raises estrogen alongside testosterone
  • Off-label use (FDA-approved only for female infertility)
Enclomiphene
Pure SERM

The active trans-isomer of clomiphene without the estrogenic zuclomiphene. More targeted action with potentially fewer side effects.

Typical Dose
12.5-25mg daily
Status
Available compounded

Early studies showed promising results for secondary hypogonadism with maintained fertility.[7] Now available through compounding pharmacies and some telehealth clinics as an alternative to TRT.

4. Female Hormone Optimization

Female hormonal health is arguably more complex than male, involving the intricate interplay of estrogen, progesterone, and testosterone across monthly cycles and significant life transitions. The consequences of hormonal decline in women—particularly during perimenopause and menopause—are profound and, until recently, undertreated.

Perimenopause: The Overlooked Transition

Perimenopause begins 4-10 years before menopause, typically in the early-to-mid 40s (sometimes earlier). It's characterized by fluctuating and declining hormones, often causing symptoms that are dismissed as "stress" or "aging."

Perimenopausal Hormone Changes
Female Health

What Happens

  • Progesterone declines first — Often drops before estrogen, creating a relative estrogen dominance
  • Cycles become irregular — Shorter, longer, heavier, lighter— unpredictable
  • Estrogen fluctuates wildly — Can be very high some cycles, crashing the next
  • FSH rises — The pituitary works harder to stimulate declining ovarian function
  • Testosterone gradually declines — Contributing to libido, energy, and muscle changes

Common Symptoms

  • Sleep disturbances (often progesterone-related)
  • Mood changes, anxiety, depression
  • Brain fog, difficulty concentrating
  • Fatigue, reduced motivation
  • Weight gain, especially abdominal
  • Decreased libido
  • Joint pain
  • Early hot flashes and night sweats
  • Menstrual changes
🌸 Early Intervention Matters

Many women suffer through years of perimenopause without realizing hormones are the cause—or that treatment is available. Early hormone support during perimenopause can prevent symptom escalation and may have long-term benefits for brain, bone, and cardiovascular health. Don't wait until menopause to seek evaluation.

Testing in Perimenopause

Hormone levels fluctuate significantly in perimenopause, making single tests less reliable. Key markers to assess:

Early Interventions

Menopause & Hormone Replacement Therapy

Menopause is defined as 12 consecutive months without a menstrual period, typically occurring around age 51. Postmenopausally, estrogen and progesterone production drops dramatically, causing the well-known symptoms and long-term health consequences.

Postmenopausal Hormone Levels
Reference
Estradiol (Premenopausal)
30-400 pg/mL
Estradiol (Postmenopausal)
<10-20 pg/mL
FSH (Postmenopausal)
>30 mIU/mL
Progesterone
<1 ng/mL

The HRT Controversy: What the Evidence Actually Shows

The Women's Health Initiative (WHI) study in 2002 caused HRT use to plummet by reporting increased breast cancer and cardiovascular risks. However, subsequent analysis has substantially revised these conclusions:[8]

✅ Current Medical Consensus

For symptomatic women under 60 or within 10 years of menopause, hormone therapy is considered safe and beneficial when appropriately prescribed. The benefits (symptom relief, bone protection, possible cardiovascular and cognitive benefits) outweigh risks for most women in this window.[9]

Benefits of Menopausal Hormone Therapy

Benefit Evidence Level Notes
Hot flash relief Strong Most effective treatment available
Sleep improvement Strong Via symptom relief and direct hormone effects
Mood and cognition Moderate Especially during perimenopause/early menopause
Bone density preservation Strong Prevents osteoporosis; reduces fracture risk
Cardiovascular protection Moderate If started early; "timing hypothesis"
Genitourinary health Strong Vaginal atrophy, urinary symptoms
Skin and collagen Moderate Maintains skin thickness and elasticity

Bioidentical Hormone Replacement Therapy (BHRT)

Bioidentical hormones are molecularly identical to the hormones your body produces, as opposed to synthetic analogs or animal-derived hormones. They include:

Estradiol Delivery Methods
BHRT
Method Dosing Notes
Transdermal patch 0.025-0.1mg/day Steady levels; no liver first-pass; safest route
Topical gel/cream 0.5-1.5mg/day Flexible dosing; may transfer to others
Vaginal ring (Femring) Systemic release Changed every 3 months
Pellets Variable 3-6 month duration; can't adjust
Oral estradiol 0.5-2mg/day Increases clotting factors; not preferred

Clinical preference: Transdermal routes (patches, gels, creams) are preferred over oral due to avoiding liver metabolism and the associated increase in clotting factors, SHBG, and inflammatory markers.[10]

Progesterone in HRT
Essential

Any woman with a uterus taking estrogen must also take progesterone to protect against endometrial hyperplasia and cancer. Unopposed estrogen stimulates endometrial growth; progesterone opposes this effect.

Options

  • Micronized progesterone (Prometrium) — 100-200mg at bedtime; also aids sleep; preferred option
  • Compounded progesterone — Creams, capsules; variable absorption
  • Synthetic progestins — Medroxyprogesterone (Provera); effective but associated with more side effects and possibly breast cancer risk

Progesterone Benefits Beyond Uterine Protection

  • Promotes sleep (metabolite allopregnanolone acts on GABA receptors)
  • Anxiolytic (calming) effects
  • Neuroprotective properties[11]
  • May have cardiovascular benefits

Women without a uterus (post-hysterectomy) don't require progesterone for uterine protection, but many providers include it for its additional benefits.

Testosterone for Women

Women produce testosterone (about 1/10th the amount of men), and it plays important roles in libido, energy, mood, and body composition. Levels decline with age and menopause.

Moderate Evidence

Multiple studies and a global consensus statement support testosterone therapy for postmenopausal women with low desire, though it remains under-prescribed.[12]

⚠️ Compounding vs. FDA-Approved

Compounded BHRT offers flexibility but lacks standardization and regulatory oversight. FDA-approved bioidentical options (estradiol patches, Prometrium) undergo quality control. The choice depends on individual needs and provider philosophy. Claims that compounded hormones are inherently safer or more "natural" are not supported—the molecules are the same.

5. Growth Hormone & Peptides

Growth hormone (GH) is perhaps the most mythologized hormone in the optimization space. It's associated with anti-aging, body recomposition, recovery, and overall vitality. While GH does decline with age and replacement can have benefits, the reality is more nuanced than the hype suggests.

Growth Hormone Basics

Growth Hormone (Somatotropin)
GH Axis

GH is released from the pituitary in pulses, primarily during deep sleep. It acts directly and through IGF-1 (Insulin-like Growth Factor 1), which is produced by the liver in response to GH.

Peak Production
Puberty/young adulthood
Decline Rate
~14% per decade after 30
Primary Release
During deep sleep

GH/IGF-1 Effects

  • Stimulates protein synthesis and muscle growth
  • Promotes lipolysis (fat breakdown)
  • Supports bone density
  • Enhances tissue repair and recovery
  • Affects skin thickness and quality
  • Influences cognitive function
  • Modulates immune function

GH Testing

GH itself is difficult to measure due to pulsatile release. IGF-1 is more stable and commonly used as a proxy for GH status:

Recombinant Human Growth Hormone (rhGH)

Pharmaceutical GH (Norditropin, Genotropin, Humatrope, etc.) is FDA-approved for growth hormone deficiency but widely used off-label for anti-aging and performance.

rhGH Therapy
Pharmaceutical
Anti-Aging Dose
0.5-2 IU/day
Performance Dose
2-6+ IU/day
Administration
Subcutaneous injection
Cost
$500-2000+/month

Documented Benefits

  • Reduced body fat, especially visceral fat[13]
  • Increased lean mass
  • Improved skin quality
  • Enhanced recovery from exercise and injury
  • Improved bone density (long-term)
  • Better sleep quality

Side Effects and Concerns

  • Water retention and joint pain — Common, often dose-dependent
  • Carpal tunnel syndrome — From fluid retention
  • Insulin resistance — GH antagonizes insulin; can worsen glucose control
  • Potential cancer risk — IGF-1 promotes cell growth; long-term effects uncertain[14]
  • Acromegaly features — At supraphysiological doses: enlarged hands, feet, facial features
  • Cost — Legitimate pharmaceutical GH is extremely expensive
🚨 Black Market GH Warning

Due to high cost, a large black market exists for GH. Underground products may be underdosed, contaminated, or contain non-GH substances. Legitimate pharmaceutical GH requires prescription and is expensive for a reason—production is complex. If the price seems too good, it probably isn't real GH.

GH Secretagogues: Peptides That Stimulate Natural GH

Rather than injecting GH directly, secretagogues stimulate the pituitary to release its own GH. This is considered more physiological (maintains pulsatility) and has fewer side effects. These are the peptides commonly discussed in the optimization community.

Sermorelin
GHRH Analog

Sermorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH)—the natural signal that tells your pituitary to release GH. It's the most studied and traditionally prescribed GH secretagogue.

Typical Dose
200-500mcg before bed
Half-Life
~10-20 minutes
Administration
Subcutaneous injection

Moderate Evidence

Benefits

  • Increases natural GH pulsatility
  • Improves sleep quality
  • May improve body composition over time
  • Better safety profile than exogenous GH
  • Maintains negative feedback (won't cause excessive GH)

Limitations

  • Effects are modest compared to direct GH
  • Requires functioning pituitary
  • Short half-life; best used at bedtime to augment natural sleep release
  • Effects diminish if somatostatin (GH-inhibiting hormone) is elevated
Ipamorelin
GHRP

Ipamorelin is a Growth Hormone-Releasing Peptide (GHRP) that stimulates GH release through the ghrelin receptor. Unlike other GHRPs, it's highly selective with minimal effects on cortisol and prolactin.

Typical Dose
100-300mcg, 1-3x/day
Half-Life
~2 hours
Key Advantage
Minimal cortisol/prolactin effect

Moderate Evidence

Ipamorelin vs. Other GHRPs

Peptide GH Release Cortisol Hunger Notes
Ipamorelin Moderate None Minimal Cleanest GHRP
GHRP-6 Strong Moderate Strong Increases appetite significantly
GHRP-2 Strong Mild Moderate Balance of effects
Hexarelin Strongest Moderate Mild Desensitizes quickly
CJC-1295
Modified GHRH

CJC-1295 is a modified GHRH with a longer half-life. It comes in two forms: with DAC (Drug Affinity Complex) for extended release, or without DAC (mod GRF 1-29) for shorter action.

CJC-1295 DAC Half-Life
~6-8 days
CJC-1295 no DAC Half-Life
~30 minutes

Common Combinations

  • CJC-1295 (no DAC) + Ipamorelin — Popular combination; GHRH + GHRP synergize for greater GH release than either alone
  • Sermorelin + Ipamorelin — Similar synergy
  • CJC-1295 with DAC — Less pulsatile, more sustained elevation; some prefer, others avoid due to "GH bleed"

Protocol note: GHRH analogs work best when somatostatin (GH-inhibiting hormone) is low—which occurs during sleep and between meals. GHRPs can override somatostatin somewhat. Combining both maximizes GH release.

MK-677 (Ibutamoren)

MK-677 is technically not a peptide—it's an oral, non-peptide ghrelin receptor agonist. It's often grouped with peptides because it similarly stimulates GH release. Its oral availability makes it popular in the self-optimization community.

MK-677 (Ibutamoren)
Oral Secretagogue
Typical Dose
10-25mg/day oral
Half-Life
~24 hours
IGF-1 Increase
40-100%+

Moderate Evidence

Clinical Research

MK-677 has undergone several clinical trials showing:[15]

  • Significant increases in GH and IGF-1 levels
  • Improved sleep quality (increased REM and stage 4 sleep)
  • Increased lean mass in elderly subjects
  • Improved nitrogen balance

Side Effects

  • Increased appetite — Significant for many users; ghrelin effect
  • Water retention and bloating — Common, especially initially
  • Elevated fasting glucose — GH effect; can worsen insulin sensitivity
  • Lethargy — Some users report fatigue, possibly from blood sugar effects
  • Numbness/tingling — Carpal tunnel-like symptoms at higher doses

Practical Considerations

  • Oral administration is a major advantage over injectable peptides
  • Long half-life means once-daily dosing
  • Doesn't desensitize like some GHRPs
  • Hunger increase can be problematic for those trying to lose fat
  • Blood glucose monitoring recommended, especially for those at risk of diabetes
⚠️ Peptide Regulation

Most GH-releasing peptides are not FDA-approved and exist in a regulatory gray zone. They're often sold as "research chemicals." Quality control varies enormously between suppliers. The FDA has taken action against some peptides, and availability may change. If pursuing peptide therapy, work with a clinic that uses reputable compounding pharmacies.

Other Peptides of Interest

BPC-157
Healing Peptide

Body Protection Compound-157, derived from gastric juice proteins. Extensively studied for tissue healing, particularly musculoskeletal injuries.

Typical Dose
250-500mcg 1-2x/day
Administration
SubQ near injury or systemic

Emerging Evidence

Research Suggests

  • Accelerates healing of tendons, ligaments, muscles, gut[16]
  • Promotes angiogenesis (new blood vessel formation)
  • May have neuroprotective effects
  • Potential for gut healing (originally studied for ulcers)

Caveat: Most research is animal studies. Human data is limited. Widely used anecdotally in sports medicine and longevity communities with reported positive outcomes.

TB-500 (Thymosin Beta-4)
Healing Peptide

A synthetic version of thymosin beta-4, a naturally occurring protein involved in tissue repair and regeneration.

Typical Protocol
2-5mg 2x/week loading, then weekly

Emerging Evidence

Proposed Benefits

  • Accelerates wound healing
  • Reduces inflammation
  • Improves flexibility
  • Promotes cell migration and differentiation

Often combined with BPC-157 for injury recovery. Evidence base is primarily preclinical.

6. Thyroid Optimization

The thyroid gland produces hormones that regulate metabolism, energy, body temperature, heart rate, and virtually every cell in the body. Thyroid dysfunction is remarkably common—affecting an estimated 12% of Americans at some point—yet often undiagnosed or undertreated.[17]

Thyroid Hormones Explained

The Hypothalamic-Pituitary-Thyroid (HPT) Axis

Hypothalamus
Releases TRH (Thyrotropin-Releasing Hormone)
Pituitary Gland
Releases TSH (Thyroid-Stimulating Hormone)
Thyroid Gland
Produces T4 (inactive) and T3 (active)
Peripheral Conversion
T4 → T3 in liver, kidneys, tissues
Key Thyroid Markers
Reference
Marker Lab Normal Optimal Range Notes
TSH 0.4-4.0 mIU/L 0.5-2.0 mIU/L Lower = more thyroid hormone
Free T4 0.8-1.8 ng/dL 1.0-1.5 ng/dL Inactive hormone; storage form
Free T3 2.3-4.2 pg/mL 3.0-4.0 pg/mL Active hormone; drives metabolism
Reverse T3 9-27 ng/dL <15 ng/dL Inactive T3; elevated in stress/illness
TPO Antibodies <35 IU/mL Negative Elevated in Hashimoto's thyroiditis
Thyroglobulin Ab <20 IU/mL Negative Another autoimmune marker

Subclinical Hypothyroidism: The Gray Zone

Many people have TSH in the upper "normal" range (2.5-4.0) with symptoms of hypothyroidism (fatigue, weight gain, cold intolerance, brain fog, depression, constipation, dry skin, hair loss). This is sometimes called subclinical hypothyroidism.

The controversy: Standard medical practice often waits until TSH exceeds 4.0-10.0 before treating. Many integrative and functional medicine practitioners treat based on symptoms and optimal (rather than normal) ranges, particularly if free T3 is low-normal.

💡 The TSH Debate

The upper limit of "normal" TSH has been debated for decades. Some endocrinologists argue it should be 2.5-3.0 rather than 4.0-4.5, based on evidence that healthy people without thyroid disease cluster below 2.5.[18] If you have symptoms and a TSH of 3.5, you may benefit from treatment even if labs say "normal."

Thyroid Treatment Options

Levothyroxine (T4)
Standard Treatment

Synthetic T4 is the standard treatment for hypothyroidism. It's converted to active T3 in peripheral tissues.

Brands
Synthroid, Levoxyl, Tirosint
Typical Starting Dose
25-50mcg/day

Considerations

  • Works well for most people
  • Requires adequate T4→T3 conversion
  • Some patients feel suboptimal on T4 alone despite "normal" labs
  • Take on empty stomach, 30-60 minutes before food
Liothyronine (T3)
Active Hormone

Synthetic T3—the active thyroid hormone. Used alone or in combination with T4 for patients who don't convert T4 well or don't respond adequately to T4 alone.

Brands
Cytomel, compounded SR T3
Typical Dose
5-25mcg/day (divided)

Considerations

  • Short half-life; often taken 2-3 times daily
  • Sustained-release compounded versions available
  • More potent; requires careful dosing
  • Can cause heart palpitations if overdosed
  • Some patients report improved energy and cognition vs. T4 alone
Natural Desiccated Thyroid (NDT)
Traditional

Derived from pig thyroid glands, NDT contains both T4 and T3 plus other thyroid components (T1, T2, calcitonin). Used for over a century before synthetic hormones.

Brands
Armour, NP Thyroid, Nature-Throid
Ratio
~4:1 T4:T3

Considerations

  • Many patients report feeling better on NDT than synthetic T4
  • Contains T3, which is more active (good or bad depending on perspective)
  • T4:T3 ratio may not match human physiology (human is ~14:1)
  • Some variability between batches (though regulated)
  • Availability issues in recent years with some brands

The NDT controversy: Mainstream endocrinology generally recommends against NDT, citing standardization concerns and the "physiological" advantage of T4-only. However, patient preference studies suggest many feel better on NDT, and some research supports combination therapy.[19]

Factors That Impair T4→T3 Conversion

Even with adequate T4, some people don't convert efficiently to active T3:

✅ Thyroid Optimization Strategy

1. Get a complete panel (not just TSH). 2. Address underlying factors (stress, nutrition, inflammation). 3. If treatment is needed, find a provider willing to optimize by symptoms and optimal ranges, not just "normal." 4. Consider combination T4/T3 therapy if T4 alone isn't working. 5. Retest 6-8 weeks after any dose change.

7. Cortisol & Adrenal Health

Cortisol is the primary stress hormone, produced by the adrenal glands in response to HPA axis activation. It's essential for life—mobilizing energy, regulating immune function, and managing inflammation. But chronic dysregulation, whether too high or too low, devastates health.

Cortisol: The Good, The Bad, The Dysregulated

Normal Cortisol Rhythm

Cortisol follows a diurnal pattern: highest in the morning (cortisol awakening response), gradually declining throughout the day, lowest at night to allow sleep.

Morning (8 AM)
10-20 mcg/dL
Afternoon
3-10 mcg/dL
Night
<5 mcg/dL

Effects of Chronic High Cortisol

Adrenal Fatigue: Controversy and Reality

"Adrenal fatigue" is a term used in alternative medicine to describe a state of HPA axis dysregulation from chronic stress—where the adrenals allegedly become "exhausted" and can't produce adequate cortisol.

The mainstream view: The Endocrine Society states that adrenal fatigue is not a real medical diagnosis. True adrenal insufficiency (Addison's disease) is a specific condition requiring diagnosis and treatment.

The nuanced view: While the term "adrenal fatigue" may be imprecise, HPA axis dysregulation is real and measurable. Chronic stress can alter cortisol patterns—blunted morning cortisol, elevated nighttime cortisol, or overall low cortisol output. These patterns correlate with symptoms (fatigue, brain fog, poor stress tolerance) even if they don't meet criteria for adrenal insufficiency.[20]

💡 HPA Axis Dysregulation Patterns

Rather than "adrenal fatigue," think of cortisol dysregulation as a spectrum:

Early stress: High cortisol, especially at night (wired but tired)
Prolonged stress: Blunted rhythm, cortisol spikes at wrong times
Late-stage dysregulation: Low cortisol throughout, poor stress response

The pattern matters more than a single reading.

Testing Cortisol

Managing Cortisol Naturally

Before considering any intervention, lifestyle factors have profound effects on cortisol regulation:

Intervention Evidence Notes
Sleep optimization Strong 7-9 hours; consistent timing; dark room
Meditation/mindfulness Strong Regular practice reduces cortisol
Moderate exercise Strong Improves HPA axis function; excessive exercise increases cortisol
Social connection Moderate Isolation is a chronic stressor
Time in nature Moderate Reduces cortisol and stress markers
Limit caffeine after noon Moderate Caffeine elevates cortisol; timing matters

Adaptogens for Cortisol Modulation

Ashwagandha (Withania somnifera)
Adaptogen

The most studied adaptogen for cortisol. Multiple RCTs show significant cortisol reduction and stress resilience improvements.[21]

Typical Dose
300-600mg/day
Best Extracts
KSM-66, Sensoril
Time to Effect
4-8 weeks

Strong Evidence

Rhodiola rosea
Adaptogen

Arctic root with evidence for stress resilience, fatigue reduction, and mild cortisol modulation. Works relatively quickly.

Typical Dose
200-600mg/day
Standardization
3% rosavins, 1% salidroside

Moderate Evidence

Phosphatidylserine
Phospholipid

A phospholipid that blunts cortisol response to stress. Particularly useful for exercise-induced cortisol elevation.

Typical Dose
400-800mg/day

Moderate Evidence

8. The Complete Testing Protocol

Comprehensive hormone testing is the foundation of any optimization strategy. Without knowing your baseline, you can't identify problems or track progress. Here's a systematic approach to testing.

The Comprehensive Hormone Panel

Essential Testing Panel
Both Sexes

Core Markers (Everyone)

Test Why Notes
Total Testosterone Primary androgen assessment Morning, fasting
Free Testosterone Bioavailable fraction Direct or calculated from SHBG
SHBG Affects free hormone levels High/low both problematic
Estradiol (sensitive) Balance with T; bone/brain health LC-MS/MS method for accuracy
LH / FSH Pituitary function; diagnose type of hypogonadism Important for root cause
TSH Thyroid screening Optimal <2.0
Free T4 Thyroid hormone status With TSH for complete picture
Free T3 Active thyroid hormone Often low despite "normal" TSH
DHEA-S Adrenal androgen; declines with age Precursor to sex hormones
Cortisol (morning) Adrenal function baseline 4-point salivary better for rhythm
Prolactin Elevated suppresses T; pituitary indicator Rule out prolactinoma
Fasting Insulin Insulin resistance affects all hormones Optimal <6 mIU/L
HbA1c Long-term glucose control Optimal <5.3%
Lipid Panel Baseline; affected by hormones Include triglycerides
CBC with Differential Hematocrit baseline (important for TRT) Also screens anemia
CMP Liver, kidney function; electrolytes Safety baseline
Vitamin D (25-OH) Affects hormone production Optimal 40-60 ng/mL

Additional for Men

  • PSA — Prostate baseline before TRT (if 40+)
  • DHT — Potent androgen; optional but informative

Additional for Women

  • Progesterone — Day 21 of cycle (luteal phase) or any time if menopausal
  • AMH — Ovarian reserve if fertility/perimenopause relevant
  • TPO Antibodies — Hashimoto's more common in women

Testing Logistics

🔬 Optimal Testing Conditions
Timing
7-10 AM for most tests
Testosterone, cortisol, and many hormones have diurnal variation. Morning testing ensures consistency and captures peak levels.
Fasting
8-12 hour fast preferred
Required for insulin, glucose, lipids. Improves accuracy of most hormone tests. Water is fine.
Sleep
Ensure normal sleep the night before
Sleep deprivation acutely lowers testosterone and alters cortisol. A bad night invalidates results.
Exercise
No intense exercise 24-48 hours prior
Heavy training transiently affects hormone levels and inflammatory markers.
Alcohol
Avoid for 48+ hours before testing
Alcohol suppresses testosterone and affects liver markers.
Consistency
Same conditions for follow-up tests
To track changes accurately, replicate timing, fasting, and conditions each time.

Testing Frequency

Situation Frequency
Baseline / Initial assessment Full panel
After starting hormone therapy 6-8 weeks (allows stabilization)
After dose adjustment 6-8 weeks
Stable on therapy Every 6-12 months
If new symptoms arise As needed
Annual check (not on therapy) Full panel annually after 40

Where to Get Testing

9. Clinic Selection & Provider Criteria

Finding the right provider for hormone optimization is critical. The wrong provider may dismiss your concerns, refuse treatment despite symptoms, or conversely, prescribe inappropriate therapy without proper evaluation. Here's how to evaluate potential providers.

Types of Providers

Provider Type Pros Cons
Endocrinologist Specialist expertise; insurance coverage Often conservative; may dismiss subclinical issues
Urologist (men) Familiar with male hormones; can address related issues Variable hormone expertise
Reproductive Endocrinologist (women) Expert in female hormones; perimenopause/menopause Often focused on fertility, not general HRT
Integrative/Functional Medicine Holistic approach; willing to optimize, not just normalize Often cash-pay; variable quality
Anti-Aging/Longevity Medicine Optimization focus; comprehensive testing Cash-pay; some are more marketing than medicine
Telehealth Hormone Clinics Accessible; streamlined; often experienced Quality varies widely; may be protocol-driven
Primary Care (interested) Continuity; knows your history Many uncomfortable with hormones; limited expertise

Green Flags: Signs of a Good Provider

Red Flags: Signs to Avoid

💡 Questions to Ask Potential Providers

"What testing do you include in an initial evaluation?"
"How do you determine optimal ranges vs. just normal?"
"What injection frequency do you typically recommend for TRT?"
"Do you prescribe hCG alongside TRT? Why or why not?"
"How do you approach patients who don't respond to T4-only thyroid?"
"What monitoring do you do, and how often?"
"What are the main risks I should know about?"

Cost Considerations

Hormone optimization can range from affordable to expensive depending on approach:

10. DIY vs. Supervised Approaches

The internet has democratized access to information about hormones, and some individuals choose to pursue optimization outside traditional medical channels. This section addresses that reality while emphasizing risks.

🚨 Important Disclaimer

We do not recommend self-treatment with hormones. This section is educational, describing what exists in the real world. Hormone therapy without medical supervision carries significant risks. The safest path is working with a qualified provider.

The Reality of Self-Treatment

A significant number of people pursue hormone optimization outside traditional healthcare:

Risks of Unsupervised Hormone Use

Risk Details
Product quality Underground products may be contaminated, underdosed, overdosed, or contain wrong substances entirely
Dosing errors Without labs, dosing is guesswork; too much or too little both problematic
Missed monitoring Hematocrit, PSA, estradiol, and other markers need tracking to catch problems early
Missed diagnosis Underlying conditions (pituitary tumors, thyroid disease) require proper diagnosis
Drug interactions Hormones interact with other medications; professional oversight needed
Emergency situations If problems arise, no medical relationship exists for support
Legal issues Testosterone and many peptides are controlled substances in many jurisdictions

Harm Reduction Principles

For those who choose self-treatment despite risks, harm reduction principles apply:

The Case for Professional Supervision

Even if accessing hormones is possible without medical involvement, there are compelling reasons to work with professionals:

✅ The Middle Path

The optimal approach for most people: Find a provider who takes hormones seriously, uses modern protocols, and treats you as a partner in your care. Use the knowledge from guides like this to have informed conversations, ask good questions, and advocate for yourself when needed. Don't settle for dismissive providers, but don't go it alone either.

11. Putting It All Together

Hormone optimization isn't about maximizing any single hormone—it's about achieving balance across the entire endocrine system while supporting overall health. Here's a practical framework for approaching optimization holistically.

🎯 The Hormone Optimization Framework
Phase 1
Foundation Assessment
Get comprehensive baseline testing. Assess symptoms systematically. Review lifestyle factors (sleep, stress, exercise, nutrition, body composition). Don't start treatment without knowing where you stand.
Phase 2
Lifestyle Optimization (8-12 weeks)
Address the controllable factors first: sleep 7-9 hours, manage stress, resistance train consistently, reach healthy body composition, fix nutrient deficiencies (Vitamin D, zinc, magnesium). These interventions can raise testosterone 100-300 ng/dL and improve thyroid function significantly.
Phase 3
Reassess
Retest after lifestyle optimization. Did levels improve? Do symptoms persist? If you've genuinely optimized foundations and still have deficiencies/symptoms, medical intervention becomes more appropriate.
Phase 4
Targeted Intervention
Address specific deficiencies with appropriate therapy. Start with the most impactful/obvious issue. One thing at a time when possible. Thyroid often before sex hormones if both are off. Monitor and adjust.
Phase 5
Optimization & Maintenance
Fine-tune protocols based on symptoms and labs. Continue lifestyle practices— they remain essential even on therapy. Regular monitoring (every 6-12 months when stable). Adjust as aging, life circumstances, and needs change.

The Hierarchy of Intervention

Not all interventions are equal. Here's a practical hierarchy:

Level Intervention Impact Risk
1 (Foundational) Sleep optimization High None
1 Stress management High None
1 Resistance training High Low
1 Body composition improvement High Low
2 (Nutritional) Vitamin D optimization Moderate Very Low
2 Zinc/Magnesium Moderate (if deficient) Very Low
2 Dietary fat adequacy Moderate None
3 (Supplemental) Ashwagandha Moderate Low
3 Tongkat Ali Low-Moderate Low
4 (Medical - Axis Stimulation) Clomiphene/Enclomiphene Moderate-High Low-Moderate
4 hCG monotherapy Moderate Low
5 (Medical - Replacement) TRT / HRT High Moderate
5 Thyroid medication High (if needed) Low-Moderate
6 (Advanced) GH/Peptides Moderate Moderate

Interactions and Synergies

Hormones don't operate in isolation. Key interactions to understand:

Age-Specific Considerations

30s

40s

50s

60s+

The Long-Term View

Hormone optimization isn't a quick fix—it's a long-term commitment to maintaining function and vitality as you age. The goals evolve:

The evidence increasingly supports that maintaining youthful hormone levels—through whatever combination of lifestyle and medical intervention is appropriate—contributes to healthspan: the years lived in good health, function, and vitality.

✅ The Ultimate Goal

Hormone optimization isn't about chasing numbers or feeling superhuman. It's about having the energy, mental clarity, physical capability, and emotional resilience to fully engage with life—to pursue your goals, maintain relationships, and experience vitality well into later decades. The hormones are tools; quality of life is the destination.

References

  1. Travison TG, et al. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196-202.
  2. American Thyroid Association. Prevalence and Impact of Thyroid Disease. thyroid.org. 2024.
  3. Tilbrook AJ, et al. Effects of stress on reproduction in non-rodent mammals. Reproduction. 2000;120(2):195-209.
  4. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  5. Kuhnert B, et al. Pharmacokinetics of testosterone gel in hypogonadal men: application of gel to one site versus four sites. Eur J Endocrinol. 2005;153(2):299-305.
  6. Leder BZ, et al. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab. 2004;89(3):1174-80.
  7. Kim ED, et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men. BJU Int. 2016;118(2):218-22.
  8. Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.
  9. The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  10. Canonico M, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation. 2007;115(7):840-5.
  11. Brinton RD, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008;29(2):313-39.
  12. Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660-4666.
  13. Rudman D, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6.
  14. Bartke A, et al. GH and ageing: pitfalls and new insights. Best Pract Res Clin Endocrinol Metab. 2017;31(1):113-125.
  15. Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149(9):601-11.
  16. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-32.
  17. Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200-35.
  18. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90(9):5483-8.
  19. Wiersinga WM, et al. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012;1(2):55-71.
  20. Guilliams TG, Edwards L. Chronic stress and the HPA axis: clinical assessment and therapeutic considerations. Standard. 2010;9(2):1-12.
  21. Chandrasekhar K, et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-62.
  22. Darbinyan V, et al. Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5. Phytomedicine. 2000;7(5):365-71.
  23. Starks MA, et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr. 2008;5:11.
  24. Pilz S, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223-5.
  25. Prasad AS, et al. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344-8.
  26. Cinar V, et al. Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion. Biol Trace Elem Res. 2011;140(1):18-23.
  27. Lopresti AL, et al. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males. Am J Mens Health. 2019;13(2):1557988319835985.
  28. Talbott SM, et al. Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10(1):28.
  29. Snyder PJ, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624.
  30. Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117.
  31. Corona G, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism. Eur J Endocrinol. 2013;168(6):829-43.
  32. Traish AM, et al. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism. J Cardiovasc Pharmacol Ther. 2017;22(5):414-428.
  33. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011;96(8):2341-53.
  34. Davis SR, Baber R. Treating menopause—MHT and beyond. Nat Rev Endocrinol. 2022;18(8):490-502.
  35. Fournier A, et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114(3):448-54.
  36. Stuenkel CA, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011.
  37. Simon JA, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90(9):5226-33.
  38. Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-1618.
  39. Sonnet E, et al. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women. Clin Endocrinol (Oxf). 2007;66(5):626-31.
  40. Johannsson G, et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 1997;82(3):727-34.
  41. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19(6):717-97.
  42. Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006;1(4):307-8.
  43. Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
  44. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone. J Clin Endocrinol Metab. 2006;91(3):799-805.
  45. Murphy MG, et al. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab. 2001;86(3):1116-25.
  46. Svensson J, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998;83(2):362-9.
  47. Chapman IM, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 1996;81(12):4249-57.
  48. Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157. Curr Neuropharmacol. 2016;14(8):857-865.
  49. Goldstein AL, et al. Thymosin beta 4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
  50. Bianco AC, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38-89.
  51. Jonklaas J, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-751.
  52. Clyde PW, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290(22):2952-8.
  53. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-81.
  54. Kumari M, et al. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality. J Clin Endocrinol Metab. 2011;96(5):1478-85.
  55. McEwen BS. Stress, adaptation, and disease: allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33-44.
  56. Hellhammer DH, et al. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34(2):163-71.
  57. Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals (Basel). 2010;3(1):188-224.
  58. Ishaque S, et al. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012;12:70.
  59. Monteleone P, et al. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol. 1992;42(4):385-8.
  60. Travison TG, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies. J Clin Endocrinol Metab. 2017;102(4):1161-1173.
  61. Rosner W, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone. J Clin Endocrinol Metab. 2007;92(2):405-13.
  62. Endocrine Society. Testosterone therapy in adult men with androgen deficiency syndromes. J Clin Endocrinol Metab. 2010;95(6):2536-59.
  63. Hackett G, et al. British Society for Sexual Medicine guidelines on adult testosterone deficiency, with statements for UK practice. J Sex Med. 2017;14(12):1504-1523.
  64. Srinivas-Shankar U, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men. J Clin Endocrinol Metab. 2010;95(2):639-50.
  65. Shores MM, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97(6):2050-8.
  66. Corona G, et al. Testosterone and cardiovascular risk: meta-analysis of interventional studies. J Sex Med. 2018;15(6):820-838.
  67. Khera M, et al. Diagnosis and treatment of testosterone deficiency. J Urol. 2016;196(1):36-44.
  68. Calof OM, et al. Adverse events associated with testosterone replacement in middle-aged and older men. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-7.
  69. Baillargeon J, et al. Risk of myocardial infarction in older men receiving testosterone therapy. Ann Pharmacother. 2014;48(9):1138-44.
  70. Vigen R, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-36.
  71. Morgentaler A, et al. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224-51.
  72. Coviello AD, et al. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93(3):914-9.
  73. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004;350(5):482-92.
  74. Santora LJ, et al. Coronary calcification in body builders using anabolic steroids. Prev Cardiol. 2006;9(4):198-201.
  75. Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol. 2010;(195):411-57.
  76. Goldman AL, et al. A reappraisal of testosterone's binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38(4):302-324.
  77. Paller CJ, et al. Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf). 2009;70(1):26-34.
  78. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833-76.
  79. Araujo AB, et al. Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):3007-19.
  80. Wu FC, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-35.
  81. Tajar A, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men. J Clin Endocrinol Metab. 2010;95(4):1810-8.
  82. Herlihy AS, et al. The metabolic syndrome and male hypogonadism. J Clin Endocrinol Metab. 2014;99(11):3821-8.
  83. Khera M. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013;66(7):729-36.
  84. Yeap BB, et al. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction. J Clin Endocrinol Metab. 2014;99(12):4565-73.
  85. Feldman HA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-98.
  86. Harman SM, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-31.

Related Reading

Questions about hormone optimization? Join the discussion.

Enter the Soma Community

Share this article